Search results (86)
« Back to NewsWellcome Discovery Award granted to Professor Robert MacLaren
24 October 2024
Professor Robert MacLaren has been awarded a prestigious Wellcome Discovery Award to advance the development of CRISPR strategies to treat inherited retinal diseases, which are a leading cause of childhood visual impairment in the UK and of blindness in people of working age.
Professor Russell Foster awarded Foreign Fellowship of INSA
2 October 2024
Award Ophthalmology People SCNi
Congratulations to Professor Russell Foster, Head of the Nuffield Laboratory of Ophthalmology and Director of the Sir Jules Thorn Sleep and Circadian Neuroscience Institute, on his election as a Foreign Fellow of the lndian National Science Academy.
Russell Foster featured in 100 Faces campaign
15 April 2024
The campaign which launched on the 15th April 2024 celebrates the stories and achievements of students who were the first in their family to go to university.
Brief sleep therapy delivered by nurses improves insomnia
11 August 2023
Researchers from the University of Oxford have found that a brief form of cognitive behavioural therapy (CBT) for insomnia, delivered by nurses in GP surgeries, significantly improves sleep and quality of life compared to sleep hygiene alone.
New imaging method trialled for retinal diseases
28 June 2023
Clinical scientists in Oxford have presented a new method of imaging of the retina that overcomes many of the drawbacks of the current standard way of diagnosing and monitoring retinal diseases like age-related macular degeneration (AMD).
Beacon Therapeutics launched to develop new generation of gene therapies for retinal diseases
12 June 2023
Beacon Therapeutics, a pioneering new biotech company, has launched with a mission to restore and improve the vision of patients with retinal diseases. The company is one of the most ambitious spinouts the University has been involved in to date, starting out with an impressive £96 million ($118.5m) in funding, the biggest launch for any company including an Oxford spin-out programme.
Colin Espie becomes a Fellow of the Academy of Medical Sciences
18 May 2023
Professor Espie is one of eight Oxford researchers to become Fellows of the Academy of Medical Sciences.
Ophthalmology Conference in Kyiv
6 March 2023
On 21 February, Robert MacLaren organised a one-day ophthalmology conference in Kyiv together with Dr Andrii Ruban, President of the Ukrainian Vitreoretinal Society.
Visit from the Sir Jules Thorn Charitable Trust
19 October 2022
Earlier this month, we were delighted to welcome the Director of the Sir Jules Thorn Charitable Trust, Richard Benson, and its Chair of Trustees, Liz Charal.
NICE recommends offering app-based treatment for people with insomnia instead of sleeping pills
24 May 2022
Hundreds of thousands of people suffering from insomnia who would usually be prescribed sleeping pills could be offered an app-based treatment programme instead, NICE has said.
How to use the science of the body clock to improve our sleep and health
16 May 2022
Ophthalmology Public engagement Research
Professor Russell Foster has written a new book about circadian neuroscience which is published by Penguin this week. This book review by Jacqueline Pumphrey was first published on the University of Oxford website.
Major research network to investigate body clock and stroke
27 October 2021
The University of Oxford is part of a new international research network to investigate the interactions between the biology of the body's internal clock and the disordered physiological processes associated with stroke.
New genetic diagnosis technology for eye disease receives major funding award
12 October 2021
Eye2Gene explores the use of AI to determine which genetic condition is causing a patient’s inherited retinal disease, by examining eye scans.
How our dreams changed during the COVID-19 pandemic
29 September 2021
This study explored associations between COVID-19 and dream recall frequency, and related social, health, and mental health factors.
New insights into the effect of exposure to dim light in the evening on the biology of the sleep-wake cycle
21 September 2021
A new study has revealed more about how exposure to dim light in the evening affects circadian health. The findings emphasise the need to optimise our artificial light exposure if we are to avoid shifting our biological clocks.
International study finds insomnia, anxiety and depression very prevalent during first phase of COVID-19 pandemic
10 September 2021
Coronavirus Ophthalmology Research SCNi
Researchers are recommending public health interventions to reduce the long-term adverse outcomes associated with chronic insomnia and mental health problems.